Pharmafile Logo

Lucid Group has four programmes shortlisted for PMEA 2019

Lucid is celebrating four of their programmes being shortlisted in four categories at this year’s PMEAs

- PMLiVE

Lucid’s talent for partnering with its clients to create magical healthcare communications is evident as they celebrate four of their programmes making the PMEA 2019 finals.

Jan Steele, Lucid Group COO and Co-founder commented, “2019 has been a transformative year for Lucid Group. We have gone through two acquisitions, allowing us to increase capability and reach. With all this change, it is a testament to our team’s dedication and passion that they continue to deliver outstanding work for our clients. I do not doubt that as we move into 2020 we will continue this incredible momentum with our work helping to transform more lives than ever before.”

PMEA recognises the achievements of responsible customer-centric business practices that provide patients with meaningful outcomes. The winners will be announced on Wednesday 27 November 2019 at the Royal Lancaster London.

More details about the shortlisted programmes can be found below:

Category: Excellence in Healthcare Professional Education and Support Programmes:   
CLEAR HORIZONS: A new era of psoriasis care
INSPIRE: Improving outcomes in paediatric cardiology

Category: Excellence in Capability Development
Global Medical Affairs as CATALYSTs for change

Category: Excellence in Innovation
DermDialogue: Bringing innovation to MSL‐led education

Excellence in Rare Diseases and Orphan Drugs
INSPIRE: Improving outcomes in paediatric cardiology

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Cultivating a learner-led culture: agile learning and the growth mindset

In this month’s Smart Thinking blog on PM.Live.com, Michelle Sweet, Learning and Development Consultant at Lucid Group, discusses the needs for a learner-led culture and a growth mindset in the...

Bluedog expands into the US with the appointment of George Pearson as Client Solutions Director

Bluedog, a Lucid Group Company, has elevated and expanded its creative team into the US with the appointment of George Pearson as Client Solutions Director.George is a highly experienced medical...

The inescapable rise of patient-centricity

The April issue of PME questions the meaning of ‘patient-centricity’ and whether we are achieving it.Patient-centricity has become a ubiquitous value within the pharmaceutical industry; however, is pharma delivering on...

Vivid welcomes magical new talent to the team

Vivid Medical Communications, a Lucid Group company, is delighted to announce two magical additions to the team.Deborah Blain joins Vivid as an Account Manager. With over 10 years’ experience in...

Easter Magic for Lucid Group

Lucid’s Futures Executives were set the challenge of planning a magical Easter surprise across its seven offices. After an egg-citing (sorry!) brainstorm the grads chose three activities.-    Egg-cellent Easter egg hunt-    You’re...

Lucid Group announces the appointment of new CFO

Lucid Group continues to build its infrastructure in line with its ambitious growth plans by appointing Michael Joyce as Chief Financial Officer (CFO).Michael has considerable experience as a CFO and...

Lucid Group Launch a Pioneering Leadership Programme for its Business Leaders

Great companies start with great leaders. However effective leadership requires skill, emotional intelligence, and most importantly, on-going self-improvement.With this in mind, Lucid Group has launched a new leadership programme for...

Leading Edge, a Lucid Group company, strengthens its senior client services team

Leading Edge, a Lucid Group company, is delighted to announce the appointment of its new Lead Client Partnership Director, Frances O’Connor.Frances is an experienced strategic healthcare communicator with expertise in...

From Cowgirl to Medical Writer – How did that happen?

Amy Jackson, Editorial Director, Lucid Group discusses her unlikely path into Medical Communications.

Measures for measures

Why pharma’s marketing metrics must close the loop